Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
02/2010
02/25/2010US20100048890 Conjugated small molecules
02/25/2010US20100048667 Thiolactones
02/25/2010US20100048528 Heterocyclic compounds as inhibitors of beta-lactamases
02/24/2010EP2157077A1 Method for producing triarylamine compound
02/24/2010EP2155737A1 Gamma secretase modulators
02/23/2010US7666880 Hydroxamate compounds which are inhibitors of histone deacetylase; may be useful as medicaments for treatment of proliferative disorders as well as other diseases involving, relating to, or associated with enzymes having histone deacetylase activities such as neurodegenerative, cardiovascular disorders
02/23/2010US7666879 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders
02/23/2010US7666876 Buprenorphine formulations for intranasal delivery
02/23/2010US7666864 Bicyclic nitroimidazole-substituted phenyl oxazolidinones
02/18/2010WO2010018686A1 Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent
02/18/2010WO2009155017A3 Novel substituted azabenzoxazoles
02/18/2010WO2009117728A3 Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
02/18/2010US20100041676 Kinase inhibitors
02/18/2010US20100041647 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responses
02/18/2010US20100040548 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
02/17/2010EP2152719A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/17/2010EP2152695A2 Gamma secretase modulators
02/17/2010EP2152664A1 Dipeptide analogs as coagulation factor inhibitors
02/17/2010EP2152082A1 Tetracyclic inhibitors of fatty acid amide hydrolase
02/17/2010CN101652373A Oxazinyl isoflavonoid compounds, medicaments and use
02/17/2010CN101648960A Method for preparing ofloxacin
02/16/2010US7662971 enzyme inhibitor for treating sleep disorders
02/16/2010US7662958 e.g. N-[3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin -3-yl}-1,1-dioxo-1,4-dihydro-1 lambda 6-thieno[2,3-e][1,2,4]thiadiazin-7-yl)methyl]methane-sulfonamide; viricides for infections caused by an RNA-containing virus; hepatitis C virus (HCV) polymerase inhibitor; liver cirrhosis
02/16/2010US7662846 Selective spirocyclic glucocorticoid receptor modulators
02/16/2010US7662833 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide
02/16/2010US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds
02/16/2010CA2562532C Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
02/16/2010CA2533548C Method of purifying macrolides
02/16/2010CA2225822C Nitroimidazole antibacterial compounds and methods of use thereof
02/11/2010WO2010017093A2 Dopamine receptor ligands with enhanced duration of action
02/11/2010WO2010016851A1 Process for selectively producing a pyridobenzoxazine carboxylic acid hemihydrate
02/11/2010WO2010016552A1 Therapeutic agent for irritable bowel syndrome
02/11/2010WO2010015628A1 Pyrazolo [5,1-b] oxazole derivatives as crf1 antagonists
02/11/2010WO2010015626A1 Crystalline forms of a pyridine derivative
02/11/2010US20100035947 Method for manufacturing neuraminic acid derivatives
02/11/2010US20100035946 Indoline anti-cancer agents
02/11/2010US20100035874 Organic compounds
02/11/2010CA2733235A1 Crystalline forms of a pyridine derivative
02/11/2010CA2733176A1 Pyrazolo [5,1-b] oxazole derivatives as crf1 antagonists
02/10/2010EP2150551A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors
02/10/2010EP2150115A1 Cyclopropyl pyrrolidine orexin receptor antagonists
02/10/2010EP2066678B1 Spiro antibiotic derivatives
02/10/2010EP1701951B1 Modulators of peripheral 5-ht receptors
02/10/2010EP1411932B1 Substituted oxazolidinones for combinational therapy
02/10/2010CN101646679A Heterocyclic antiviral compounds
02/09/2010US7659296 2-{1-[4-(3,3-dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid; 1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid amide; stimulate bone formation, restore bone quality, acne, alopecia, Alzheimer's disease etc.
02/09/2010US7659265 5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; menopause therapy; contraceptive; anticancer agents
02/09/2010US7659263 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C
02/09/2010US7659244 Rapamycin peptides conjugates: synthesis and uses thereof
02/09/2010CA2437505C Isoxazoline derivatives as anti-depressants
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/04/2010US20100029937 Novel and practical process for exclusively producing (s)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
02/04/2010US20100029933 Pure form of rapamycin and a process for recovery and purification thereof
02/04/2010US20100029731 Method for preparing largazole analogs and uses thereof
02/04/2010US20100029669 3-(substituted ethyl)-rifamycin derivatives useful as antimicrobial agents
02/04/2010US20100029666 Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors
02/04/2010US20100029633 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/04/2010CA2729045A1 Pyrimidine compounds, compositions and methods of use
02/03/2010EP2149571A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
02/03/2010EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents
02/03/2010CN101637624A Medical devices containing rapamycin analogs
02/03/2010CN100586952C Derivative of oxazolocamptothecin ester, preparation method and application
02/03/2010CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/02/2010US7655673 39-desmethoxyrapamycin, compositions and methods of use thereof
02/02/2010US7655658 Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
02/02/2010US7655650 Oxadiazine derivatives
02/02/2010US7655649 Inhibitors of Akt activity
02/02/2010US7655648 Antibacterial agents
02/02/2010US7655642 3-cyano-quinoline derivatives with antiproliferative activity
01/2010
01/28/2010WO2010011964A2 Imaging agents useful for identifying ad pathology
01/28/2010WO2010011959A1 Antiviral compounds
01/28/2010WO2010010435A2 Fused oxazole and thiazole derivatives as trpms modulators
01/28/2010WO2009122176A3 Rapamycin carbonate esters
01/28/2010WO2009107850A3 Fused heterocyclic derivative and use thereof
01/28/2010US20100022766 Biosynthetic gene cluster for the production of a complex polyketide
01/28/2010US20100022607 Diazonamide analogs
01/28/2010US20100022593 Process for Producing Anticancer Agent LL-D45042
01/28/2010US20100022524 Tricyclic tetrahydroquinoline antibacterial agents
01/28/2010US20100022516 4,5-Disubstituted-2-aryl pyrimidines
01/28/2010US20100022508 Antiviral compounds
01/28/2010US20100022500 Macrocyclic Lactams and Pharmaceutical Use Thereof
01/28/2010CA2731738A1 Imaging agents useful for identifying ad pathology
01/27/2010EP2147000A1 Method of purification of rapamycin and its analogs by use of cascade chromatography
01/27/2010EP2146983A1 Pyrazoles useful in the treatment of inflammation
01/27/2010EP2146972A2 Heterocyclic compounds containing the morpholine nucleus their preparation and use
01/27/2010EP1554286B1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
01/26/2010US7652032 5-Thioxylopyranose compounds
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010US7652010 Azabicyclic aryl derivatives and their medical use
01/26/2010US7652008 Tricyclic benzopyran compound as anti-arrhythmic agents
01/26/2010US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof
01/26/2010CA2303934C Tetrazole-containing rapamycin analogs with shortened half-lives
01/26/2010CA2275345C Pro-drugs and counterparts of camptothecin, their application as medicines
01/21/2010WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists
01/21/2010WO2010006521A1 2-methyl-5h-pyrazolo[1,5-a][3,1]benzoxazin-5-imine compound, the preparation and the use thereof
01/21/2010WO2010006485A1 Benzoxazinopyrazoles and their ring-opening compound
01/21/2010WO2009145456A3 Heterocyclic derivatives
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 220